tribenzor (0713-0874) | FunFoxMeds NDC

Drug Facts

Product Profile

Brand Name tribenzor

Generic Name olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide

Labeler cosette pharmaceuticals, inc.

Dosage Form TABLET, FILM COATED

Routes

ORAL

Active Ingredients

amlodipine besylate 5 mg/1, hydrochlorothiazide 12.5 mg/1, olmesartan medoxomil 20 mg/1

Manufacturer

Cosette Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 0713-0874

Product ID 0713-0874_004953ba-fe11-03eb-e063-6394a90a638c

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category NDA

Application Number NDA200175

Listing Expiration 2026-12-31

Marketing Start 2022-09-01

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 07130874

Hyphenated Format 0713-0874

Supplemental Identifiers

RxCUI

999967 999971 999986 999990 999991 999995 999996 1000000 1000001 1000005

UPC

0307130876308 0307130874304 0307130877305 0307130878302 0307130875301

UNII

0J48LPH2TH 864V2Q084H 6M97XTV3HD

NUI

N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tribenzor (source: ndc)

Generic Name olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide (source: ndc)

Application Number NDA200175 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

5 mg/1
12.5 mg/1
20 mg/1

source: ndc

Packaging

30 TABLET, FILM COATED in 1 BOTTLE (0713-0874-30)

source: ndc

Packages (1)

0713-0874-30 30 TABLET, FILM COATED in 1 BOTTLE (0713-0874-30)

Ingredients (3)

amlodipine besylate (5 mg/1) hydrochlorothiazide (12.5 mg/1) olmesartan medoxomil (20 mg/1)

Linked Drug Pages (1)

Tribenzor ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "004953ba-fe11-03eb-e063-6394a90a638c", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0307130876308", "0307130874304", "0307130877305", "0307130878302", "0307130875301"], "unii": ["0J48LPH2TH", "864V2Q084H", "6M97XTV3HD"], "rxcui": ["999967", "999971", "999986", "999990", "999991", "999995", "999996", "1000000", "1000001", "1000005"], "spl_set_id": ["2f56d0bc-236b-41a0-9fc0-21cdfea8d890"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["Cosette Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0713-0874-30)", "package_ndc": "0713-0874-30", "marketing_start_date": "20220901"}], "brand_name": "Tribenzor", "product_id": "0713-0874_004953ba-fe11-03eb-e063-6394a90a638c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "0713-0874", "generic_name": "olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide", "labeler_name": "Cosette Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tribenzor", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "20 mg/1"}], "application_number": "NDA200175", "marketing_category": "NDA", "marketing_start_date": "20220901", "listing_expiration_date": "20261231"}